medicine

Stories 161 - 180 | << Prev   Next >>

Bloodthinner Can Help Frostbite Victims

Drug spares digits, study says

(Newser) - A clot-busting drug is remarkably effective in treating frostbite patients, according to new research from the University of Utah health center, reports the Los Angeles Times. Patients whose treatment included tissue plasmingoen activator (tPA) kept 90% of affected fingers and toes; patients treated before the drug was in use had...

Women Alerted to Symptoms of Ovarian Cancer

Subtle signs may aid early diagnosis of stealthy disease

(Newser) - In an effort to dispel the belief that ovarian cancer has few early symptoms, experts are urging women to acquaint themselves with an array of common conditions associated with one of the deadliest types of cancer. The new guidelines acknowledge for the first time that late diagnosis is not a...

China Finds Fake Protein in IV Drips

Counterfeit albumin discovered in hospitals and pharmacies

(Newser) - In yet another product-safety scandal, fake blood protein has been found in IV drips in 60 hospitals and pharmacies in northeastern China, the BBC reports. Albumin, or plasma protein, is administered to patients suffering from burns or undergoing open-heart surgery; the counterfeit contained no protein at all. 

Americans Go Abroad, Online for New Diet Pill

Hung up in FDA approval process, pill's already scoring big

(Newser) - The weight loss drug Acomplia is stuck in FDA limbo, but that isn't stopping Americans from ordering it off the Internet or buying it in Europe, where it's legal. If the government rules that its lowering of weight and cholesterol balances out the possible side effects, including suicide and depression,...

Genes Give Up Secrets of 7 Serious Diseases

Landmark study sheds light on diabetes, depression, more

(Newser) - In an outcome one scientist describes as a "new dawn," researchers have identified genetic variations linked to seven common diseases, opening the door to improved tests and treatments. The study, which focused on depression, Crohn's disease, coronary artery disease, hypertension, rheumatoid arthritis, and Type 1 and 2 diabetes,...

Controversy Rages Over Diabetes Drug's Heart Risks

FDA official says superiors ordered her to back off serious warning

(Newser) - Troubling questions about the diabetes drug Avandia persisted yesterday as an FDA official revealed that she was barred from recommending a critical warning about the medication, the Times reports. In the run-up to congressional hearings that began today, manufacturer GlaxoSmithKline rushed to disseminate interim clinical findings in hopes of blunting...

Nigeria Sues Pfizer Over Deadly Tests

$7B suit claims drug giant carried out disastrous trials on children

(Newser) - Nigeria is suing pharma giant Pfizer for $7 billion, claiming the company carried out improper trials on children. 200 children in the state of Kano died, and others developed deformities, after Pfizer tested Trovan, an experimental antibiotic, during a 1996 meningitis outbreak. Nigeria claims the tests were unauthorized, but Pfizer...

UK to Patients Who Smoke: Put That Out

National Health Service imposes four-week window before surgery

(Newser) - Smokers in Britain must kick the habit for at least four weeks before undergoing routine surgery or the National Health Service will deny them the operations, the Daily Mail reports. Doctors will use blood tests to enforce the new policy, which could affect up to 500,000 smokers awaiting procedures...

New Drug Battles Liver Cancer
New Drug Battles Liver Cancer
Jun 4, 2007 7:37 AM CDT

New Drug Battles Liver Cancer

Nexavar, already approved for kidney cancer, shows promise in liver patients

(Newser) - An impressive clinical trial has produced what could be the first effective drug treatment for liver cancer, the New York Times reports. Nexavar, which blocks both the blood supply to the tumor and proteins that spur tumor growth, extended the lives of patients in the trial by almost three months,...

Kidney Donor Reality Show Was a Hoax

Broadcaster draws praise for raising awareness of transplant-organ shortage

(Newser) - A controversial Dutch reality show featuring a dying woman’s choice of a kidney recipient aired last night—and was revealed as a hoax. The "donor" was an actor; the contestants were real patients who were in on the prank. A producer said the goal was to call attention...

Glaxo Stems Stock Slide Over Avandia

Medical chief rebuts findings on heart risks; claims comparable to other drugs

(Newser) - Glaxo shares pulled out of a tailspin after the pharma giant defended its second biggest selling drug, Avandia, against claims that it triggers heart attacks.  A sharply worded letter from the company's chief medical officer on the website of medical journal The Lancet pointed out that the increased incidence...

Drug-Resistant TB Patient Flies Commercial

Carrier crossed Atlantic twice, putting passengers at risk

(Newser) - A man infected with drug-resistant tuberculosis boarded two transatlantic flights in two weeks, CNN reports, putting his fellow passengers at risk. Planes are equipped with air filters that should catch the rod-shaped TB bacili, but the CDC recommends anyone on Air France 385, from Atlanta to Paris May 12, or...

Eye-Care Recall Reverberates on Wall Street

Product problem seen influencing bids for Bausch & Lomb

(Newser) - In the wake of reports linking its Complete MoisturePlus contact lens solution to a rare eye infection that can lead to blindness, Advanced Medical Optics has recalled the product. Competitor Bausch & Lomb's stock price dropped on the news, since the recall may put AMO's plans to enter the bidding...

Scientists ID New Breast Cancer Genes

Biggest breakthrough in a decade may advance prevention, treatment

(Newser) - Four newly discovered genes can increase a woman's chance of developing breast cancer by as much as 60%, say scientists who hail the isolation of the genes as the biggest advance in the field since 1994. The breakthrough raises hopes for more advanced treatment and even prevention of breast cancer...

New Cancer Ideas Compete for $1 Million

A Harvard doctor and two hedge fund managers set up contest for cancer cure

(Newser) - Doctors and hedge fund managers are joining forces to battle cancer with a million-dollar prize for the most imaginative new approach. The Gotham Prize for Cancer Research will be awarded to the most innovative essay—posted to the website—on finding a cure for cancer. Leading medical researchers will judge...

Drug Company Nemesis Strikes Again
Drug Company Nemesis
Strikes Again
May 22, 2007 1:32 PM CDT

Drug Company Nemesis Strikes Again

Crusading cardiologist took on Vioxx, now Avandia, for heart risks

(Newser) - The doctor who helped to raise concerns about the painkiller Vioxx is back—with the study released earlier this week linking the same company's popular diabetes drug, Avandia, to higher risk of heart attacks. The Wall Street Journal looks at 58-year-old cardiologist Steven Nissen's role in identifying and publicizing drug...

Diabetes Drug Ups Heart Risk
Diabetes
Drug Ups
Heart Risk
May 21, 2007 3:15 PM CDT

Diabetes Drug Ups Heart Risk

New study documents dangers of Avandia, but company nixes recall

(Newser) - A popular diabetes drug may increase heart attack risks, a study reported in the New England Journal of Medicine concludes. Patients who took Avandia, which treats Type 2 diabetes, were 43% more likely to have a heart attack than those who took a placebo, the Cleveland Clinic study found.

Psych Drugs Drove Kid Crazy
Psych Drugs Drove Kid Crazy
May 18, 2007 9:44 PM CDT

Psych Drugs Drove Kid Crazy

Careless prescriptions turned shy chess nerd into into belligerent hulk

(Newser) - The careless prescription of anti-psychotic drugs, often by psychiatrists who draw pay checks from the companies who make them, has drawn attention in the New York Times recently. Now Ann Bauer, writing in Salon, draws an intimate portrait of the effects of such carelessness on one autistic teenager, who turned...

Britain OKs Human-Animal Hybrids for Research

(Newser) - The British government has reversed its stance on the creation of human-animal hybrid embryos and will propose allowing scientists to use them as sources of stem cells. Scientists developing treatments for incurable diseases would be allowed to grow the hybrid embryos for no longer than two weeks, and implanting them...

Big Pharma Loses Generic Drug Fight
Big Pharma Loses Generic
Drug Fight
May 17, 2007 10:23 AM CDT

Big Pharma Loses Generic Drug Fight

Deal for developing nations first blow by Dems in Congress

(Newser) - Congress and the White House have agreed to give developing nations more access to affordable generic drugs by easing some patent enforcement rules. Tucked into a broader trade agreement passed last week, the provision is the first blow to American pharmaceutical companies since the Democrats won control of Congress, the ...

Stories 161 - 180 | << Prev   Next >>
Most Read on Newser